Condition
Chronic Myeloid Leukemia, Chronic Phase clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Chronic Myeloid Leukemia, Chronic Phase clinical trials that are recruiting, at sites in 12 countries (most in South Korea (3), Italy (2), Spain (2)). By phase: Phase 2 (2), Phase 1/2 (1), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 12Countries
Newest Chronic Myeloid Leukemia, Chronic Phase clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Potential of asciminib in early chronic‑phase CML | Phase 2 | Barcelona and 10 other locations | Recruiting | May 10, 2024 |
| Treatment-free remission with asciminib plus TKIs in chronic-phase chronic myeloid leukemia | Phase 2 | Incheon, Incheon | Recruiting | Apr 16, 2024 |
| Evaluating TERN-701 for Chronic Myeloid Leukemia | Phase 1/2 | Birmingham, Alabama and 53 other locations | Recruiting | Dec 8, 2023 |
| Evaluating ponatinib treatment in chronic myeloid leukemia patients | — | Cagliari and 4 other locations | Recruiting | Nov 7, 2023 |
| Efficacy and safety of Radotinib for chronic myeloid leukemia patients who failed previous treatments | Phase 3 | Barnaul and 17 other locations | Recruiting | Mar 9, 2018 |
All recruiting trials (5)
-
Potential of asciminib in early chronic‑phase CML
This trial will see if asciminib alone, or asciminib plus nilotinib, helps adults newly diagnosed with chronic‑phase, BCR‑ABL–positive CML reach deep molecular responses and remain off treatment.
-
Treatment-free remission with asciminib plus TKIs in chronic-phase chronic myeloid leukemia
This trial tests whether adding asciminib to ongoing TKI therapy helps people with chronic-phase CML who lost remission after stopping TKIs regain and sustain a deeper molecular response so they can attempt stopping treatment again.
-
Evaluating TERN-701 for Chronic Myeloid Leukemia
This study is testing a new drug called TERN-701 to see if it can safely help people with chronic myeloid leukemia who have already been treated.
-
Evaluating ponatinib treatment in chronic myeloid leukemia patients
This study is testing how well the drug ponatinib works and how safe it is for people with chronic myeloid leukemia who are on their second, third, or fourth round of treatment.
-
Efficacy and safety of Radotinib for chronic myeloid leukemia patients who failed previous treatments
This study is testing if Radotinib can help people with chronic myeloid leukemia who haven't had success with other treatments feel better and stay safe while using it.
Related topics
Quick answers
How many Chronic Myeloid Leukemia, Chronic Phase clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 12 countries. The most sites are in South Korea (3 trials), Italy (2 trials), Spain (2 trials), Australia (1 trial), France (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 1/2: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.